Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a

Vaillant, A.; Bazinet, M.; Pantea, V.; Placinta, G.; Moscalu, I.; Cebotarescu, V.; Cojuhari, L.; Jimbei, P.; Iarovoi, L.; Smesnoi, V.; Musteata, T.; Jucov, A.; Krawczyk, A.

期刊名称Journal of Hepatology
作者Vaillant, A.; Bazinet, M.; Pantea, V.; Placinta, G.; Moscalu, I.; Cebotarescu, V.; Cojuhari, L.; Jimbei, P.; Iarovoi, L.; Smesnoi, V.; Musteata, T.; Jucov, A.; Krawczyk, A.
卷第68卷
印刷ISSN0168-8278
文件大小53.75KB
发表时间2018-04
DOI10.1016/s0168-8278(18)31283-2

发现好书期刊，享受阅读乐趣

Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a